BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 30604635)

  • 1. Low-grade epithelial ovarian cancer: what a radiologist should know.
    Elsherif S; Javadi S; Viswanathan C; Faria S; Bhosale P
    Br J Radiol; 2019 Mar; 92(1095):20180571. PubMed ID: 30604635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the Management and Prognosis of Ovarian Cancer Due to the New FIGO and WHO Classifications: A Case Series Observational Descriptive Study. Seven Years of Follow-up.
    Gomes Ferreira M; Sancho de Salas M; González Sarmiento R; Doyague Sánchez MJ
    Int J Gynecol Cancer; 2018 Oct; 28(8):1461-1470. PubMed ID: 30045138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current update on malignant epithelial ovarian tumors.
    Elsherif SB; Bhosale PR; Lall C; Menias CO; Itani M; Butler KA; Ganeshan D
    Abdom Radiol (NY); 2021 Jun; 46(6):2264-2280. PubMed ID: 34089360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revised FIGO staging system for cancer of the ovary, fallopian tube, and peritoneum: important implications for radiologists.
    Saida T; Tanaka YO; Matsumoto K; Satoh T; Yoshikawa H; Minami M
    Jpn J Radiol; 2016 Feb; 34(2):117-24. PubMed ID: 26696400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound characteristics of early-stage high-grade serous ovarian cancer.
    Suh-Burgmann E; Brasic N; Jha P; Hung YY; Goldstein RB
    Am J Obstet Gynecol; 2021 Oct; 225(4):409.e1-409.e8. PubMed ID: 33992598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1, Ki67, and β-Catenin Immunoexpression Is Not Related to Differentiation, Platinum Response, or Prognosis in Women With Low- and High-Grade Serous Ovarian Carcinoma.
    Sallum LF; Andrade L; Bastos Eloy da Costa L; Ramalho S; Ferracini AC; Natal RA; Brito ABC; Sarian LO; Derchain S
    Int J Gynecol Cancer; 2018 Mar; 28(3):437-447. PubMed ID: 29465506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current FIGO staging classification for cancer of ovary, fallopian tube and peritoneum].
    Šišovská I; Minář L; Felsinger M; Anton M; Bednaříková M; Hausnerová J; Jandáková E; Weinberger V
    Ceska Gynekol; 2017; 82(3):230-236. PubMed ID: 28593778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving population-based statistics for rare epithelial ovarian cancers.
    Matsuo K; Machida H; Matsuzaki S; Grubbs BH; Klar M; Roman LD; Sood AK; Gershenson DM; Wright JD
    Gynecol Oncol; 2020 Apr; 157(1):3-11. PubMed ID: 31954534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade serous ovarian carcinoma: A comprehensive literature review.
    Goulding EA; Simcock B; McLachlan J; van der Griend R; Sykes P
    Aust N Z J Obstet Gynaecol; 2020 Feb; 60(1):27-33. PubMed ID: 31849044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Staging of Ovarian Cancer.
    O'Shea AS
    Methods Mol Biol; 2022; 2424():3-10. PubMed ID: 34918284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low Grade Serous Ovarian Carcinoma: from the molecular characterization to the best therapeutic strategy.
    Della Pepa C; Tonini G; Santini D; Losito S; Pisano C; Di Napoli M; Cecere SC; Gargiulo P; Pignata S
    Cancer Treat Rev; 2015 Feb; 41(2):136-43. PubMed ID: 25573350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradigm Shift in the Management Strategy for Epithelial Ovarian Cancer.
    Fujiwara K; McAlpine JN; Lheureux S; Matsumura N; Oza AM
    Am Soc Clin Oncol Educ Book; 2016; 35():e247-57. PubMed ID: 27249730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival rates for international federation of gynecology and obstetrics stage III ovarian carcinoma by cell type: a study of 262 unselected patients with uniform pathologic review.
    Seidman JD; Yemelyanova A; Cosin JA; Smith A; Kurman RJ
    Int J Gynecol Cancer; 2012 Mar; 22(3):367-71. PubMed ID: 22237384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-grade serous carcinoma: molecular features and contemporary treatment strategies.
    Angarita AM; Cholakian D; Fader AN
    Expert Rev Anticancer Ther; 2015; 15(8):893-9. PubMed ID: 26040191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grading ovarian serous carcinoma using a two-tier system.
    Malpica A; Deavers MT; Lu K; Bodurka DC; Atkinson EN; Gershenson DM; Silva EG
    Am J Surg Pathol; 2004 Apr; 28(4):496-504. PubMed ID: 15087669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Part I drafted from the short text of the French Guidelines entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Diagnosis management, surgery, perioperative care, and pathological analysis)].
    Lavoué V; Huchon C; Akladios C; Alfonsi P; Bakrin N; Ballester M; Bendifallah S; Bolze PA; Bonnet F; Bourgin C; Chabbert-Buffet N; Collinet P; Courbiere B; De la Motte Rouge T; Devouassoux-Shisheboran M; Falandry C; Ferron G; Fournier L; Gladieff L; Golfier F; Gouy S; Guyon F; Lambaudie E; Leary A; Lécuru F; Lefrère-Belda MA; Leblanc E; Lemoine A; Narducci F; Ouldamer L; Pautier P; Planchamp F; Pouget N; Ray-Coquard I; Rousset-Jablonski C; Sénéchal-Davin C; Touboul C; Thomassin-Naggara I; Uzan C; You B; Daraï E
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):100-110. PubMed ID: 30686724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian Cancer, the Revised FIGO Staging System, and the Role of Imaging.
    Javadi S; Ganeshan DM; Qayyum A; Iyer RB; Bhosale P
    AJR Am J Roentgenol; 2016 Jun; 206(6):1351-60. PubMed ID: 27042752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redefining the standard of care for low-grade serous ovarian cancer.
    Manning-Geist BL; Cantor T; O'Cearbhaill RE; Grisham RN
    Clin Adv Hematol Oncol; 2024 Jun; 22(5):205-226. PubMed ID: 38805312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrauterine Pelvic Serous Carcinomas: Current Update on Pathology and Cross-sectional Imaging Findings.
    Katabathina VS; Amanullah FS; Menias CO; Chen MM; Valente PT; Chintapalli KN; Prasad SR
    Radiographics; 2016; 36(3):918-32. PubMed ID: 27163599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study.
    Bodurka DC; Deavers MT; Tian C; Sun CC; Malpica A; Coleman RL; Lu KH; Sood AK; Birrer MJ; Ozols R; Baergen R; Emerson RE; Steinhoff M; Behmaram B; Rasty G; Gershenson DM
    Cancer; 2012 Jun; 118(12):3087-94. PubMed ID: 22072418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.